1. Home
  2. DNA vs EHAB Comparison

DNA vs EHAB Comparison

Compare DNA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • EHAB
  • Stock Information
  • Founded
  • DNA 2008
  • EHAB 2014
  • Country
  • DNA United States
  • EHAB United States
  • Employees
  • DNA N/A
  • EHAB N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • EHAB Hospital/Nursing Management
  • Sector
  • DNA Health Care
  • EHAB Health Care
  • Exchange
  • DNA Nasdaq
  • EHAB Nasdaq
  • Market Cap
  • DNA 466.4M
  • EHAB 401.6M
  • IPO Year
  • DNA N/A
  • EHAB N/A
  • Fundamental
  • Price
  • DNA $7.76
  • EHAB $10.26
  • Analyst Decision
  • DNA Sell
  • EHAB Hold
  • Analyst Count
  • DNA 5
  • EHAB 3
  • Target Price
  • DNA $17.25
  • EHAB $8.50
  • AVG Volume (30 Days)
  • DNA 1.2M
  • EHAB 291.4K
  • Earning Date
  • DNA 05-06-2025
  • EHAB 05-07-2025
  • Dividend Yield
  • DNA N/A
  • EHAB N/A
  • EPS Growth
  • DNA N/A
  • EHAB N/A
  • EPS
  • DNA N/A
  • EHAB N/A
  • Revenue
  • DNA $237,417,000.00
  • EHAB $1,032,300,000.00
  • Revenue This Year
  • DNA N/A
  • EHAB $5.33
  • Revenue Next Year
  • DNA $16.74
  • EHAB $4.86
  • P/E Ratio
  • DNA N/A
  • EHAB N/A
  • Revenue Growth
  • DNA 13.76
  • EHAB N/A
  • 52 Week Low
  • DNA $5.00
  • EHAB $6.85
  • 52 Week High
  • DNA $38.60
  • EHAB $10.70
  • Technical
  • Relative Strength Index (RSI)
  • DNA 53.73
  • EHAB 79.60
  • Support Level
  • DNA $6.42
  • EHAB $7.89
  • Resistance Level
  • DNA $8.18
  • EHAB $8.12
  • Average True Range (ATR)
  • DNA 0.62
  • EHAB 0.32
  • MACD
  • DNA 0.04
  • EHAB 0.27
  • Stochastic Oscillator
  • DNA 65.37
  • EHAB 97.46

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: